Trends in the use of prenatal diagnosis in New York State and the impact of biochemical screening on the detection of Down syndrome: 1984–1993
- 1 December 1997
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 17 (12) , 1113-1124
- https://doi.org/10.1002/(sici)1097-0223(199712)17:12<1113::aid-pd200>3.0.co;2-7
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Effect of chorionic villus sampling on utilization of prenatal diagnosis in women of advanced maternal ageClinical Genetics, 2008
- EARLY AMNIOCENTESIS AT 10–12 WEEKS' GESTATIONPrenatal Diagnosis, 1996
- Genetic diagnosis by chorionic villus sampling before 8 gestational weeks: Efficiency, reliability, and risks on 317 completed pregnanciesPrenatal Diagnosis, 1992
- Chorionic villus sampling and limb abnormalitiesThe Lancet, 1992
- Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alpha‐fetoprotein, and agePrenatal Diagnosis, 1991
- Fetal limb constriction: A possible complication of CVSPrenatal Diagnosis, 1989
- Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalitiesPrenatal Diagnosis, 1987
- Maternal age and amniocentesis: Should this be lowered to 30 years?Prenatal Diagnosis, 1986
- Temporal changes in the utilization of amniocentesis for prenatal diagnosis by women of advanced maternal age, 1976–1983Prenatal Diagnosis, 1985
- MATERNAL SERUM ALPHA-FETOPROTEIN MEASUREMENT: A SCREENING TEST FOR DOWN SYNDROMEThe Lancet, 1984